fbpx

QQQ
+ 2.31
364.32
+ 0.63%
BTC/USD
-819.70
60852.72
-1.33%
DIA
+ 3.70
345.43
+ 1.06%
SPY
+ 3.26
439.24
+ 0.74%
TLT
-0.85
146.73
-0.58%
GLD
-2.66
170.66
-1.58%

Tilray Stockholders Approve Increase In Number Of Shares To Help Drive $4B In Revenue, Stock Trades Down

September 10, 2021 2:26 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Tilray Stockholders Approve Increase In Number Of Shares To Help Drive $4B In Revenue, Stock Trades Down

Shares of cannabis giant Tilray Inc. (NASDAQ:TLRY) (TSX: TLRY) are trading down on Friday afternoon, after the company reported that its stockholders have approved an increase in the number of authorized shares of its common stock.

As such, the cannabis company said that with additional authorized shares, it can accelerate its progress toward its goal of delivering $4 billion in revenue, a goal Tilray CEO Irwin Simon told Benzinga it intended to achieve by the end of fiscal 2024. The company is also looking to increase its retail market share from 16% to 30% by FY24 end.

Merger Made In Heaven

Following its merger with Aphria (NASDAQ: APHA) (NASDAQ: APHA), which closed in May 2021, the new Tilray has made substantial strides across its business, by driving increased revenue through rapidly expanding its international medical business, introducing a new medical brand in Canada while increasing its share in that market, and making strong progress towards its target of $80 million in synergies.

The merger also made Tilray one of the largest cannabis companies in the world.

Tilray further intends to actively pursue accretive and strategic acquisition opportunities in the U.S., Canada, and globally, Simon said in a recent exclusive interview on Benzinga Cannabis Hour.

Encuentra nuestro contenido en Español en El Planteo:

  •  

  •  

 

 

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to Benzinga Podcasts and our YouTube channel.


Related Articles

What Investors Need To Know On Heels Of Tilray's Q1 Earnings Release

What Investors Need To Know On Heels Of Tilray's Q1 Earnings Release

On Thursday, Tilray, Inc. read more
Tilray CEO: Expand The Company's Medical Cannabis Business, 'Opportunities Are Tremendous'

Tilray CEO: Expand The Company's Medical Cannabis Business, 'Opportunities Are Tremendous'

Irwin Simon, CEO of Canada-based cannabis company Tilray (NASDAQ: TLRY), said Thursday on CNBC that the company intends to drive growth by building its medica read more
Tilray CEO Received Nearly $30M In Compensation In Calendar 2021, $13.2M In Cash Bonuses...So Far

Tilray CEO Received Nearly $30M In Compensation In Calendar 2021, $13.2M In Cash Bonuses...So Far

Canadian cannabis giant Tilray Inc.’s (NASDAQ: TLRY) (TSX: TLRY) CEO Irwin Simon has received nearly $30 million in total compensation so far in calendar 2021, with nearly half of that sum paid in cash, according to a recently disclosed read more
Analyst: Updating Tilray's Numbers Ahead Of Aug Qtr Print

Analyst: Updating Tilray's Numbers Ahead Of Aug Qtr Print

Cantor Fitzgerald analyst Pablo Zuanic shared an update on Tilray's (NASDAQ: TLRY) Aug qtr sales estimates in his Thursday note. read more